Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Sensei robotic catheter system Stories

2008-10-14 09:00:45

St. Jude Medical, Inc. (NYSE:STJ) today announced it has received approval for European CE Marking of its SJM Confirm(TM) implantable cardiac monitor (ICM), a compact device designed to detect atrial fibrillation (AF) and other abnormal heart rhythms. About the size of a computer thumb drive, the SJM Confirm ICM is the smallest implantable cardiac monitor available. It is implanted just under the skin (subcutaneously) in the upper chest region and can be implanted in an outpatient...

2008-10-07 09:00:56

Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac rhythm disorders, has launched the TOCCATA (TOuCh+ for CATheter Ablation) clinical study to evaluate the safety of the TactiCath(TM) system with enrollment gaining momentum. TOCCATA is a 70 patient European multi-center safety study. Constructed to gain the CE mark for the treatment of atrial arrhythmias, secondary endpoints were designed to evaluate the value of...

2008-10-01 18:00:49

CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the release of its new atrial fibrillation (AF) reporting package to enhance its current AF Management Program. The CardioNet AF Management Program offers a robust and comprehensive tool to the physician for the diagnosis, treatment and management of their AF patients. The program additionally provides physicians with...

2008-09-03 09:00:47

Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that a team of physicians led by Professor Nick Cheshire at St. Mary's Hospital, part of the Imperial College Healthcare NHS Trust, in London, England, utilized Hansen Medical's Sensei(TM) Robotic Catheter System and Artisan(TM) Control Catheter to aid deployment of stent grafts used to treat an abdominal aortic...

2008-09-02 15:00:30

CARLSBAD, Calif., Sept. 2 /PRNewswire/ -- Ablation Frontiers, Inc., announced today that two important studies, involving its innovative atrial fibrillation ablation products were presented by Dr. Lucas Boersma of the St. Antonius Hospital in Nieuwegein, Netherlands at the European Society of Cardiology (ESC) congress. One of the world's most prestigious scientific meetings for cardiologists, the ESC meetings took place from August 30 - September 3 in Munich, Germany. Dr. Boersma's first...

2008-08-19 09:01:12

Cardima, Inc. (OTCBB: CADM), a medical device company focused on the treatment of Atrial Fibrillation ("AF") and manufacturer of the Cardima's Surgical Ablation System and the EP Revelation(R) line of therapeutic catheters, has received approval from the Food and Drug Administration, Ministry of Public Health, in Thailand, to market its three main lines of products, including the diagnostic products, the EP therapeutic REVELATION line of products and the Surgical Ablation System. "The market...

2008-08-13 15:01:02

AUSTIN, Texas, Aug. 13 /PRNewswire/ -- This week, doctors at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center became the first in the nation to implement the CoHesion(TM) 3D Visualization Module -- an enhancement to the state-of-the art Hansen Robotic system used to treat cardiac arrhythmias. With the visualization module, patients undergoing the ablation treatment for heart arrhythmias are exposed to about 30 percent less radiation than without the new technology,...

2008-07-31 18:00:49

Hansen Medical, Inc. (NASDAQ: HNSN), a developer of new generation flexible robotic technology, today reported its business highlights and financial results for the second quarter ended June 30, 2008. Recent Business Highlights -- Systems: The company recognized revenue on eight Sensei Robotic Systems and shipped two additional systems for which revenue is expected to be recognized in the third quarter. Through June 30, 2008, the company has recognized revenue on a total...

2007-11-01 18:00:45

Hansen Medical, Inc. (NASDAQ: HNSN) announced today that it has signed a definitive agreement to acquire AorTx, Inc., of Redwood City, Calif. AorTx is an early stage developer of "percutaneous" or catheter-based valve technology. This acquisition will allow Hansen Medical to leverage its Sensei(TM) Robotic Catheter system, which is currently marketed for electrophysiology procedures, into the rapidly developing market for percutaneous heart valve therapy. "It has been a core element of our...

2004-11-25 03:00:18

Aspirin not panacea * Though millions of Americans take aspirin daily to reduce chances of heart disease and stroke, doctors recently found that aspirin doesn't work the same for everyone. Researchers have identified patients with aspirin resistance, in whom aspirin doesn't have the same blood-thinning effect it does in others. Without the blood-thinning effect, aspirin has no bearing on reducing heart attack risk. One researcher found that approximately 10% to 30% of patients don't respond...